Tag: Magmaris
TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascular Therapeutics annu...
Biotronik announces positive data for Magmaris
A press release from Biotronik highlights data from the BIOSOLVE-IV registry outlining procedura...
CRT 2019: Early resorption and low complications demonstrated for Magmaris
A press release reports that preliminary data from the BIOSOLVE-IV registry strengthen the clini...
Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into clinical practice
Preliminary data from the BIOSOLIVE-IV registry are consistent with the favourable safety outcom...
EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable scaffold
Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its c...
TCT 2017: Pooled analysis of Magmaris studies continue to show no instances of scaffold thrombosis at 12 months
Data presented during the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 Octob...
EuroPCR 2017: Low risk of scaffold thrombosis with Magmaris
Data presented at EuroPCR (16–19 May, Paris, France) indicate that a metallic bioresorbable scaf...
Magnesium 1,000 programme reveals high deployment success for Biotronik’s Magmaris scaffold
Biotronik has released details of the clinical performance of its Magmaris magnesium scaffold in...
TCT 2016: Physicians discuss their positive experiences of using a metallic scaffold
At a symposium at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2...
